Bristol-Myers Squibb Co
BMYMP
Company Profile
Business description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Contact
Sector
Healthcare
Stock type
Industry
Drug Manufacturers - General
Fiscal Year End
Employees
Bristol-Myers Squibb Co News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,674.60 | 21.90 | 0.25% |
| CAC 40 | 7,770.95 | 37.45 | 0.48% |
| DAX 40 | 21,042.00 | 51.69 | 0.25% |
| Dow JONES (US) | 44,025.81 | 537.98 | 1.24% |
| FTSE 100 | 8,548.29 | 27.75 | 0.33% |
| HKSE | 19,836.39 | 270.16 | -1.34% |
| NASDAQ | 19,756.78 | 126.58 | 0.64% |
| Nikkei 225 | 39,536.98 | 509.00 | 1.30% |
| NZX 50 Index | 13,037.14 | 15.76 | -0.12% |
| S&P 500 | 6,049.24 | 52.58 | 0.88% |
| S&P/ASX 200 | 8,424.10 | 21.70 | 0.26% |
| SSE Composite Index | 3,215.37 | 27.25 | -0.84% |